Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 17 Dec 2020 for Lipocine Inc.. Read the official filing
Filing timeline
BuySaleJeffrey Arvin Fink
Insider track record
Disclosed buys
0
Disclosed sells
1
Signal history
No signal scores available.
Jeffrey Arvin Fink: trading record in brief
Jeffrey Arvin Fink discloses dealings in Lipocine Inc. to SEC (Form 4). Over a trading history stretching from 29 December 2017 to 16 December 2020, the count stands at 3 filings.
The open-market record consists of 1 sale worth €2,726, with no purchase. The rest of the record consists of 2 option exercises.
Most recently, on 17 December 2020, the filings show an option exercise in Lipocine Inc. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jeffrey Arvin Fink
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
5,625 shares0Common StockSEC:0001638599-20-000979:0
1,875 shares0Common StockSEC:0001638599-18-000024:0
938 shares@ US$3.47100.0% of flowCommon stockSEC:0001638599-18-000024:1
3 of 3 declarations
